Hepatitis B Vaccine IP

Trade Name: GeneVac-B
Available Strength : 1 ML
Available Combination : "Each ml dose contains. Purified Hepatitis-B surface antigen 20 mcg. Adsorbed on Aluminium hydroxide, Al+++ ? 1.25 mg. Preservative: ? 0.01% Thiomersal."
Packing : 1x1ml
Pack Insert/Leaflet : YES
Therapeutic use : GeneVac-B Adult Vaccine is an active immunizing agent. It is used for the prevention of hepatitis B infection in individuals considered at risk of exposure to hepatitis B virus.
Capacity : 1000

Additional Information

The most common markets for this product include the following countries. Please inquire with us if your country or region is not listed:

Asia: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

Europe: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, etc.

OCEANIA: Australia, New Zealand, Fiji, etc.